BACKGROUND: Potassium currents contribute to action potential duration (APD) and arrhythmogenesis. In heart failure, Ca/calmodulin-dependent protein kinase II (CaMKII) is upregulated and can alter ion channel regulation and expression. METHODS AND RESULTS: We examine the influence of overexpressing cytoplasmic CaMKIIdelta(C), both acutely in rabbit ventricular myocytes (24-hour adenoviral gene transfer) and chronically in CaMKIIdelta(C)-transgenic mice, on transient outward potassium current (I(to)), and inward rectifying current (I(K1)). Acute and chronic CaMKII overexpression increases I(to,slow) amplitude and expression of the underlying channel protein K(V)1.4. Chronic but not acute CaMKII overexpression causes downregulation of I(to,fast), as well as K(V)4.2 and KChIP2, suggesting that K(V)1.4 expression responds faster and oppositely to K(V)4.2 on CaMKII activation. These amplitude changes were not reversed by CaMKII inhibition, consistent with CaMKII-dependent regulation of channel expression and/or trafficking. CaMKII (acute and chronic) greatly accelerated recovery from inactivation for both I(to) components, but these effects were acutely reversed by AIP (CaMKII inhibitor), suggesting that CaMKII activity directly accelerates I(to) recovery. Expression levels of I(K1) and Kir2.1 mRNA were downregulated by CaMKII overexpression. CaMKII acutely increased I(K1), based on inhibition by AIP (in both models). CaMKII overexpression in mouse prolonged APD (consistent with reduced I(to,fast) and I(K1)), whereas CaMKII overexpression in rabbit shortened APD (consistent with enhanced I(K1) and I(to,slow) and faster I(to) recovery). Computational models allowed discrimination of contributions of different channel effects on APD. CONCLUSIONS: CaMKII has both acute regulatory effects and chronic expression level effects on I(to) and I(K1) with complex consequences on APD.
BACKGROUND:Potassium currents contribute to action potential duration (APD) and arrhythmogenesis. In heart failure, Ca/calmodulin-dependent protein kinase II (CaMKII) is upregulated and can alter ion channel regulation and expression. METHODS AND RESULTS: We examine the influence of overexpressing cytoplasmic CaMKIIdelta(C), both acutely in rabbit ventricular myocytes (24-hour adenoviral gene transfer) and chronically in CaMKIIdelta(C)-transgenic mice, on transient outward potassium current (I(to)), and inward rectifying current (I(K1)). Acute and chronic CaMKII overexpression increases I(to,slow) amplitude and expression of the underlying channel protein K(V)1.4. Chronic but not acute CaMKII overexpression causes downregulation of I(to,fast), as well as K(V)4.2 and KChIP2, suggesting that K(V)1.4 expression responds faster and oppositely to K(V)4.2 on CaMKII activation. These amplitude changes were not reversed by CaMKII inhibition, consistent with CaMKII-dependent regulation of channel expression and/or trafficking. CaMKII (acute and chronic) greatly accelerated recovery from inactivation for both I(to) components, but these effects were acutely reversed by AIP (CaMKII inhibitor), suggesting that CaMKII activity directly accelerates I(to) recovery. Expression levels of I(K1) and Kir2.1 mRNA were downregulated by CaMKII overexpression. CaMKII acutely increased I(K1), based on inhibition by AIP (in both models). CaMKII overexpression in mouse prolonged APD (consistent with reduced I(to,fast) and I(K1)), whereas CaMKII overexpression in rabbit shortened APD (consistent with enhanced I(K1) and I(to,slow) and faster I(to) recovery). Computational models allowed discrimination of contributions of different channel effects on APD. CONCLUSIONS:CaMKII has both acute regulatory effects and chronic expression level effects on I(to) and I(K1) with complex consequences on APD.
Authors: W F An; M R Bowlby; M Betty; J Cao; H P Ling; G Mendoza; J W Hinson; K I Mattsson; B W Strassle; J S Trimmer; K J Rhodes Journal: Nature Date: 2000-02-03 Impact factor: 49.962
Authors: Tong Zhang; Lars S Maier; Nancy D Dalton; Shigeki Miyamoto; John Ross; Donald M Bers; Joan Heller Brown Journal: Circ Res Date: 2003-04-03 Impact factor: 17.367
Authors: S Tessier; P Karczewski; E G Krause; Y Pansard; C Acar; M Lang-Lazdunski; J J Mercadier; S N Hatem Journal: Circ Res Date: 1999-10-29 Impact factor: 17.367
Authors: Andrew W Varga; Li-Lian Yuan; Anne E Anderson; Laura A Schrader; Gang-Yi Wu; Jennifer R Gatchel; Daniel Johnston; J David Sweatt Journal: J Neurosci Date: 2004-04-07 Impact factor: 6.167
Authors: Vladimir E Bondarenko; Gyula P Szigeti; Glenna C L Bett; Song-Jung Kim; Randall L Rasmusson Journal: Am J Physiol Heart Circ Physiol Date: 2004-05-13 Impact factor: 4.733
Authors: Ilona Bodi; James N Muth; Harvey S Hahn; Natasha N Petrashevskaya; Marta Rubio; Sheryl E Koch; Gyula Varadi; Arnold Schwartz Journal: J Am Coll Cardiol Date: 2003-05-07 Impact factor: 24.094
Authors: Stefan Wagner; Tim Seidler; Eckard Picht; Lars S Maier; Victor Kazanski; Nils Teucher; Wolfgang Schillinger; Burkert Pieske; Gerrit Isenberg; Gerd Hasenfuss; Harald Kögler Journal: Cardiovasc Res Date: 2003-11-01 Impact factor: 10.787
Authors: Thomas J Hund; Olha M Koval; Jingdong Li; Patrick J Wright; Lan Qian; Jedidiah S Snyder; Hjalti Gudmundsson; Crystal F Kline; Nathan P Davidson; Natalia Cardona; Matthew N Rasband; Mark E Anderson; Peter J Mohler Journal: J Clin Invest Date: 2010-09-27 Impact factor: 14.808
Authors: Hiroki Takanari; Vincent J A Bourgonje; Magda S C Fontes; Antonia J A Raaijmakers; Helen Driessen; John A Jansen; Roel van der Nagel; Bart Kok; Leonie van Stuijvenberg; Mohamed Boulaksil; Yoshio Takemoto; Masatoshi Yamazaki; Yukiomi Tsuji; Haruo Honjo; Kaichiro Kamiya; Itsuo Kodama; Mark E Anderson; Marcel A G van der Heyden; Harold V M van Rijen; Toon A B van Veen; Marc A Vos Journal: Cardiovasc Res Date: 2016-06-29 Impact factor: 10.787
Authors: Sara Gattoni; Åsmund Treu Røe; Michael Frisk; William E Louch; Steven A Niederer; Nicolas P Smith Journal: J Physiol Date: 2016-06-26 Impact factor: 5.182
Authors: M Said; R Becerra; C A Valverde; M A Kaetzel; J R Dedman; C Mundiña-Weilenmann; X H Wehrens; L Vittone; A Mattiazzi Journal: J Mol Cell Cardiol Date: 2011-08-19 Impact factor: 5.000
Authors: Gregory S Hoeker; Mohamed A Hanafy; Robert A Oster; Donald M Bers; Steven M Pogwizd Journal: J Cardiovasc Pharmacol Date: 2016-03 Impact factor: 3.105